HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

6-diazo-5-oxo-L-norleucine

HCID 9087
New noteNew reactionRequest quotes
Print preview
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
157-03-9
Standard SMILES
[N-]=[N+]=CC(=O)CC[C@H](N)C(=O)O
InChIKey
YCWQAMGASJSUIP-YFKPBYRVSA-N
Molecular formula
C6H9N3O3
Average molar mass
171.15 g/mol
Monoisotopic mass
171.06439116

Overview

6-diazo-5-oxo-L-norleucine is a non-proteinogenic L-alpha-amino acid that is L-norleucine which is substituted at position 5 by an oxo group and at position 6 by a diazo group. It is as inhibitor of various glutamine-utilising enzymes. It has a role as an EC 6.3.5.5 [carbamoyl-phosphate synthase (glutamine-hydrolysing)] inhibitor, an EC 6.3.4.2 [CTP synthase (glutamine hydrolyzing)] inhibitor, an EC 6.3.5.3 (phosphoribosylformylglycinamidine synthase) inhibitor, an EC 6.3.5.2 [GMP synthase (glutamine-hydrolysing)] inhibitor, a glutamine antagonist, an EC 2.4.2.14 (amidophosphoribosyltransferase) inhibitor, an EC 6.3.5.1 [NAD(+) synthase (glutamine-hydrolysing)] inhibitor, an EC 6.3.5.4 [asparagine synthase (glutamine-hydrolysing)] inhibitor, an antiviral agent, an antibacterial agent, an antimetabolite, an analgesic, an antineoplastic agent, an EC 3.5.1.2 (glutaminase) inhibitor, an apoptosis inducer and a bacterial metabolite. It is a ketone, a diazo compound and a non-proteinogenic L-alpha-amino acid. It is a tautomer of a 6-diazo-5-oxo-L-norleucine zwitterion.

Names & identifiers

Preferred name
6-diazo-5-oxo-L-norleucine
IUPAC
(2S)-2-amino-6-diazo-5-oxohexanoic acid
English name
6-Diazo-5-oxo-L-norleucine
Molecular formula
C6H9N3O3
Molecular weight
171.15

Names & synonyms

6-diazo-5-oxo-L-norleucine157-03-9diazooxonorleucineL-DONNSC-736503J0H273KZCHEBI:138889DTXSID501028846NSC73656 Diazo 5 oxo L norleucineRefChem:132775DTXCID201514482
Show more names
DOND2141H-L-Don-OHdon(pharmaceutical)diazo-oxo-norleucineH-6-DIAZO-5-OXO-NLE-OHH-NLE(6-DIAZO-5-OXO)-OHL-Nle(6-Diazo-5-oxo)-OH
Norleucine, 6-diazo-5-oxo-6-Diazo-5-oxo-L-nor-LeucineL-Norleucine, 6-diazo-5-oxo-MFCD00037218(2S)-2-amino-6-diazo-5-oxohexanoic acidDON (pharmaceutical)(2S)-2-amino-6-diazo-5-oxo-hexanoic acid(S)-2-Amino-6-diazo-5-oxocaproic acid

Database identifiers

CAS
157-03-9
PubChem CID
9087
DTXSID
DTXSID501028846
ChEMBL
CHEMBL4303391、CHEMBL97485

Properties

Computed structural properties

XLogP
-3.5
Topological polar surface area
82.4 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
5
Rotatable bonds
5
Heavy atoms
12
Formal charge
0
Complexity
232

Experimental & physicochemical properties

DrugsPharmaceuticals -> Antibiotics

Physicochemical properties

Melting point
145 °C · 145 °C
Boiling point
301.12 °C · 301.12°C (rough estimate)
Density
1.3994 · 1.3994 (rough estimate)
refractive index
1.58 · 1.5800 (estimate)
storage temp.
-20 °C · -20°C
solubility
DMSO (Slightly, Heated, Sonicated), Water (Slightly)
form
crystalline
color
light yellow
Merck
13 · 13,3026
BRN
1725815 · 1725815
Stability
Hygroscopic
InChI
InChI=1/C6H9N3O3/c7-5(6(11)12)2-1-4(10)3-9-8/h3,5H,1-2,7H2,(H,11,12)/t5-/s3
InChIKey
YCWQAMGASJSUIP-GQMHJJTINA-N

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P261, P262, P264, P270, P271, P280, P301+P316, P302+P352, P304+P340, P316, P321, P330, P361+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 40 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesAcute Tox. 3 (100%)

Safety data

F
8
PPE
Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges
wgk
3
rtecs
RC6340000
ridadr
UN 2811 6.1/PG 3
risk_code
23/24/25
Signal word
Danger
Symbol(GHS)
GHS06
hazard_code
T
safety_code
36/37/39-45
Storage Class
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard statements
H301+H311+H331
Hazard Classifications
Acute Tox. 3 DermalAcute Tox. 3 InhalationAcute Tox. 3 Oral
Precautionary statements
P261-P264-P280-P301+P310-P302+P352+P312-P304+P340+P311

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 2 items

Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms.

Antimetabolites that are useful in cancer chemotherapy.

Applications

Uses6-Diazo-5-oxo-L-norleucine (DON) has been used as an inhibitor of glutamine synthetase–glutamine(amide)-2-oxoglutarate aminotransferase.

General DescriptionChemical structure: amino acid derivatives

Additional notes · 1 item

DefinitionChEBI: 6-diazo-5-oxo-L-norleucine is a non-proteinogenic L-alpha-amino acid that is L-norleucine which is substituted at position 5 by an oxo group and at position 6 by a diazo group. It is as inhibitor of various glutamine-utilising enzymes. It has a role as a bacterial metabolite, an analgesic, an antibacterial agent, an antiviral agent, an antineoplastic agent, an EC 6.3.5.5 [carbamoyl-phosphate synthase (glutamine-hydrolysing)] inhibitor, an EC 6.3.4.2 [CTP synthase (glutamine hydrolyzing)] inhibitor, an EC 6.3.5.3 (phosphoribosylformylglycinamidine synthase) inhibitor, an EC 6.3.5.2 [GMP synthase (glutamine-hydrolysing)] inhibitor, an antimetabolite, a glutamine antagonist, an apoptosis inducer, an EC 2.4.2.14 (amidophosphoribosyltransferase) inhibitor, an EC 3.5.1.2 (glutaminase) inhibitor, an EC 6.3.5.1 [NAD(+) synthase (glutamine-hydrolysing)] inhibitor and an EC 6.3.5.4 [asparagine synthase (glutamine-hydrolysing)] inhibitor. It is a non-proteinogenic L-alpha-amino acid, a diazo compound and a ketone. It is a tautomer of a 6-diazo-5-oxo-L-norleucine zwitterion.

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes
ChEBI
CHEBI:138889
UNII
03J0H273KZ
EC Number
621-136-2
Nikkaji
J6.130A
SMILES
C(C(=O)C=[N+]=[N-])C[C@H](N)C(=O)O |&1:7,r|
FDA UNII
3 J0H273KZ · 03J0H273KZ
NCI Drug Dictionary
diazooxonorleucine
UNSPSC Code
12352209 · 12352209
NACRES
26 · NA.26
Symbol(GHS)
6 · GHS06
Signal word
Danger
Hazard statements
301 · H301+H311+H331
Precautionary statements
261 · P261-P264-P280-P301+P310-P302+P352+P312-P304+P340+P311
PPE
2 · Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges
Hazard Codes
T
Risk Statements
23 · 23/24/25
Safety Statements
36 · 36/37/39-45
RIDADR
2811 · UN 2811 6.1/PG 3
WGK Germany
3 · 3
RTECS
6340000 · RC6340000
F
8 · 8
Storage Class
6.1 C · 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
3 DermalAcute · Acute Tox. 3 DermalAcute Tox. 3 InhalationAcute Tox. 3 Oral